Adriamycin-a review
- PMID: 1107570
- DOI: 10.1093/jnci/55.6.1265
Adriamycin-a review
Similar articles
-
Adriamycin. A new anticancer drug with significant clinical activity.Ann Intern Med. 1974 Feb;80(2):249-59. doi: 10.7326/0003-4819-80-2-249. Ann Intern Med. 1974. PMID: 4590654 Review. No abstract available.
-
[Experiences with N-Lost phosphamide esters].Dtsch Med Wochenschr. 1970 Mar 6;95(10):491-7. doi: 10.1055/s-0028-1108490. Dtsch Med Wochenschr. 1970. PMID: 4905291 Clinical Trial. German. No abstract available.
-
Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease.Cancer. 1971 Oct;28(4):837-43. doi: 10.1002/1097-0142(1971)28:4<837::aid-cncr2820280406>3.0.co;2-4. Cancer. 1971. PMID: 4329505 No abstract available.
-
[Adriamycin as a single agent in various forms of advanced neoplasia of adults and children (author's transl)].Tumori. 1974 Sep-Oct;60(5):373-91. doi: 10.1177/030089167406000504. Tumori. 1974. PMID: 4617354 Clinical Trial. Italian. No abstract available.
-
Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.Cancer Treat Rep. 1979 May;63(5):809-15. Cancer Treat Rep. 1979. PMID: 378369 Review. No abstract available.
Cited by
-
CCNU-adriamycin association induces earlier and more severe nephropathy in rats.Arch Toxicol. 1988;61(4):282-91. doi: 10.1007/BF00364851. Arch Toxicol. 1988. PMID: 3377683
-
Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).Cancer Chemother Pharmacol. 1979;3(4):223-7. doi: 10.1007/BF00254735. Cancer Chemother Pharmacol. 1979. PMID: 535130
-
Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.Experientia. 1978 Oct 15;34(10):1255-7. doi: 10.1007/BF01981401. Experientia. 1978. PMID: 570116
-
Time dependency of adriamycin and adriamycinol kinetics.Cancer Chemother Pharmacol. 1983;10(2):120-4. doi: 10.1007/BF00446223. Cancer Chemother Pharmacol. 1983. PMID: 6831625
-
The clinical evaluation of analogs--III. Anthracyclines.Cancer Chemother Pharmacol. 1980;4(1):5-10. doi: 10.1007/BF00255451. Cancer Chemother Pharmacol. 1980. PMID: 7363403 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources